"Multiple myeloma" trang 1 - tải miễn phí từ tailieunhanh
Naringin inhibits multiple myeloma cells proliferation by Altering mitochondrial function

Naringin inhibits multiple myeloma cells proliferation by Altering mitochondrial function
7    24    1
MULTIPLE MYELOMA - A QUICK REFLECTION ON THE FAST PROGRESS

MULTIPLE MYELOMA - A QUICK REFLECTION ON THE FAST PROGRESS
334    84    0
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
8    78    0
N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
10    87    1
Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma

Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma
11    58    1
Infection risks in multiple myeloma: A systematic review and meta-analysis of randomized trials from 2015 to 2019

Infection risks in multiple myeloma: A systematic review and meta-analysis of randomized trials from 2015 to 2019
11    48    1
Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK
10    27    1
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: A retrospective multicenter study from China

Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: A retrospective multicenter study from China
10    5    1
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): A randomised, double-blinded, placebo-controlled, phase 3 trial

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): A randomised, double-blinded, placebo-controlled, phase 3 trial
14    9    1
Quality of life analyses in patients with multiple myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Quality of life analyses in patients with multiple myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
10    58    1
Patient perspectives on considerations, tradeofs, and experiences with multiple myeloma treatment selection: A qualitative descriptive study

Patient perspectives on considerations, tradeofs, and experiences with multiple myeloma treatment selection: A qualitative descriptive study
10    4    1
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway
13    59    1
Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): An outcome measure to support routine symptom assessment in myeloma care

Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): An outcome measure to support routine symptom assessment in myeloma care
13    101    0
Rationale and design of the Germanspeaking myeloma multicenter group (GMMG) trial HD6: A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

Rationale and design of the Germanspeaking myeloma multicenter group (GMMG) trial HD6: A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
11    95    0
Improving the assessment of quality of life in the clinical care of myeloma patients: The development and validation of the Myeloma Patient Outcome Scale (MyPOS)

Improving the assessment of quality of life in the clinical care of myeloma patients: The development and validation of the Myeloma Patient Outcome Scale (MyPOS)
12    54    1
In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma

In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma
8    76    0
Plasmacytoma in patients with multiple myeloma: Morphology and immunohistochemistry

Plasmacytoma in patients with multiple myeloma: Morphology and immunohistochemistry
8    99    0
Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma
14    68    0
Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)

Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)
16    108    0
Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review

Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review
13    92    0